Pyrimidyl sulphone amide derivatives as chemokine receptor modulators
Abstract:
A compound of formula (I), pharmaceutically acceptable salt, solvate or in vivo hydrolysable ester thereof for the treatment of asthma, allergic rhinitis, COPD, inflammatory bowel disease, irritable bowel syndrome, osteoarthritis, osteoporosis, rheumatoid arthritis, psoriasis or cancer.
Public/Granted literature
Information query
Patent Agency Ranking
0/0